Tag: Jubilant Pharmova
Jubilant seeks DGCI authorization for oral Remdesivir next steps
On 19 April 2021, Noida-Delhi NCR-based Jubilant Pharmova announced the development of a novel oral formulation of Remdesivir by its subsidiary Jubilant Pharma with...